Unknown

Dataset Information

0

Trends in Troponin-Only Testing for AMI in Academic Teaching Hospitals and the Impact of Choosing Wisely®.


ABSTRACT: BACKGROUND:Identifying hospitals that are both early and consistent adopters of high-value care can help shed light on the culture and practices at those institutions that are necessary to promote high-value care nationwide. The use of troponin to diagnose acute myocardial infarction (AMI), and not to test for myoglobin or creatine kinase-MB (CK-MB), is a high-value recommendation of the Choosing Wisely® campaign. OBJECTIVE:To examine the variation in cardiac biomarker testing and the effect of the Choosing Wisely® troponin-only recommendation for the diagnosis of AMI. DESIGN:A retrospective observational study using administrative ordering data from Vizient's Clinical Database/Resource Manager. SETTING:Ninety-one academic medical centers from the fourth quarter of 2013 through the third quarter of 2016. PATIENTS:Hospitalized patients with a principal discharge diagnosis of AMI. INTERVENTION:The Choosing Wisely® recommendation to order troponin-only testing to diagnose AMI was released during the first quarter of 2015. RESULTS:In 19 hospitals, troponin-only testing was consistently ordered to diagnose AMI before the Choosing Wisely® recommendation and throughout the study period. In 34 hospitals, both troponin and myoglobin/CK-MB were ordered to diagnose AMI even after the Choosing Wisely® recommendation. In 26 hospitals with low rates of troponin-only testing before the Choosing Wisely® recommendation, the release of the recommendation was associated with a statistically significant increase in the rate of troponin-only testing to diagnose AMI. CONCLUSIONS:In institutions with low rates of troponin-only testing prior to the Choosing Wisely® recommendation, the recommendation was associated with a significant increase in the rate of troponin-only testing.

SUBMITTER: Prochaska MT 

PROVIDER: S-EPMC5895078 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Trends in Troponin-Only Testing for AMI in Academic Teaching Hospitals and the Impact of Choosing Wisely®.

Prochaska Micah T MT   Hohmann Samuel F SF   Modes Matthew M   Arora Vineet M VM  

Journal of hospital medicine 20170920 12


<h4>Background</h4>Identifying hospitals that are both early and consistent adopters of high-value care can help shed light on the culture and practices at those institutions that are necessary to promote high-value care nationwide. The use of troponin to diagnose acute myocardial infarction (AMI), and not to test for myoglobin or creatine kinase-MB (CK-MB), is a high-value recommendation of the Choosing Wisely® campaign.<h4>Objective</h4>To examine the variation in cardiac biomarker testing and  ...[more]

Similar Datasets

| S-EPMC6204196 | biostudies-literature
| S-EPMC5473033 | biostudies-literature
| S-EPMC8368552 | biostudies-literature
| S-EPMC5570467 | biostudies-literature
| S-EPMC8776509 | biostudies-literature
| S-EPMC8317587 | biostudies-literature
| S-EPMC10186090 | biostudies-literature
| S-EPMC4999471 | biostudies-other
| S-EPMC6813785 | biostudies-other
| S-EPMC6287976 | biostudies-literature